Innovating Works

SISAQOL-IMI

Financiado
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT O...
489.74K€ | Lider
TUTTI PASTA
221.68K€ | Participante
KU Leuven
165.50K€ | Participante
ESD EVALUATION SOFTWARE DEVELOPMENT GMBH
103.74K€ | Participante
UNIVERSITY HEALTH NETWORK
27.26K€ | Participante
EMA
78.76K€ | Participante
BII GMBH
480.00K€ | Participante
NATIONAL CANCER CENTER
BAYER AKTIENGESELLSCHAFT
200.00K€ | Participante
QUEEN'S UNIVERSITY AT KINGSTON
UKLFR
41.50K€ | Participante
UNIVLEEDS
98.74K€ | Participante
MODUS OUTCOMES SAS
77.70K€ | Participante
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
200.00K€ | Participante
MUI
427.50K€ | Participante
FUNDACIÓN PÚBLICA MIGUEL SERVET
22.94K€ | Participante
UNSYD
56.00K€ | Participante
UGent
156.50K€ | Participante
UoB
82.50K€ | Participante
ALLEA
69.00K€ | Participante
Myeloma Patients Europe AISBL
262.50K€ | Participante
REGIONH
13.20K€ | Participante
Pfizer RD UK Limited
600.00K€ | Participante
ADELPHI VALUES LTD
60.00K€ | Participante
THE CRITICAL PATH INSTITUTE (C-PATH) NON PROFIT CO...
Innovasjon Norge
347.46K€ | Participante
European Society for Medical Oncology (ESMO)
120.00K€ | Participante
CLINICAL HOSPITAL CENTER RIJEKA
62.70K€ | Participante
IMIM
20.00K€ | Participante
Leiden University Medical Center
390.50K€ | Participante
NATIONAL CANCER CENTER
12.20K€ | Participante
Queen's University at Kingston
20.00K€ | Participante
Critical Path Institute
90.00K€ | Participante